Entry
Name
Human papillomavirus infection - Vulpes lagopus (Arctic fox)
Description
Human papillomavirus (HPV) is a non-enveloped, double-stranded DNA virus. HPV infect mucoal and cutaneous epithelium resulting in several types of pathologies, most notably, cervical cancer. All types of HPV share a common genomic structure and encode eight proteins: E1, E2, E4, E5, E6, and E7 (early) and L1 and L2 (late). It has been demonstrated that E1 and E2 are involved in viral transcription and replication. The functions of the E4 protein is not yet fully understood. E5, E6, and E7 act as oncoproteins. E5 inhibits the V-ATPase, prolonging EGFR signaling and thereby promoting cell proliferation. The expression of E6 and E7 not only inhibits the tumor suppressors p53 and Rb, but also alters additional signalling pathways. Among these pathways, PI3K/Akt signalling cascade plays a very important role in HPV-induced carcinogenesis. The L1 and L2 proteins form icosahedral capsids for progeny virion generation.
Class
Human Diseases; Infectious disease: viral
BRITE hierarchy
Pathway map
Ortholog table
Organism
Vulpes lagopus (Arctic fox) [GN:
vlg ]
Gene
121477470 DVL3; segment polarity protein dishevelled homolog DVL-3 isoform X1 [KO:K02353 ]
121499761 DVL2; segment polarity protein dishevelled homolog DVL-2 isoform X1 [KO:K02353 ]
121499953 DVL1; segment polarity protein dishevelled homolog DVL-1 isoform X1 [KO:K02353 ]
121495587 APC2; adenomatous polyposis coli protein 2 isoform X1 [KO:K02085 ]
121494692 MAGI1; membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1 isoform X1 [KO:K05631 ]
121500588 PARD6A; partitioning defective 6 homolog alpha isoform X1 [KO:K06093 ]
121497282 CDC42; cell division control protein 42 homolog isoform X1 [KO:K04393 ]
121473797 LLGL2; LLGL scribble cell polarity complex component 2 isoform X1 [KO:K06094 ]
121499619 LLGL1; lethal(2) giant larvae protein homolog 1 isoform X1 [KO:K06094 ]
121478506 COL6A5; LOW QUALITY PROTEIN: collagen alpha-5(VI) chain [KO:K06238 ]
121480007 TNFRSF1A; tumor necrosis factor receptor superfamily member 1A isoform X1 [KO:K03158 ]
121499974 TRADD; tumor necrosis factor receptor type 1-associated DEATH domain protein isoform X1 [KO:K03171 ]
121498932 FASLG; tumor necrosis factor ligand superfamily member 6 [KO:K04389 ]
121475736 tumor necrosis factor receptor superfamily member 6-like [KO:K04390 ]
121473330 SLC9A3R1; Na(+)/H(+) exchange regulatory cofactor NHE-RF1 [KO:K13365 ]
121495681 PPP2CA; serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform [KO:K04382 ] [EC:3.1.3.16 ]
121484445 PPP2R1A; serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform isoform X1 [KO:K03456 ]
121499587 PPP2R1B; serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A beta isoform isoform X1 [KO:K03456 ]
121490126 PPP2R2C; protein phosphatase 2, regulatory subunit B, gamma isoform X1 [KO:K04354 ]
121484411 PPP2R2D; serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B delta isoform isoform X1 [KO:K04354 ]
121496949 PPP2R2A; serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B alpha isoform isoform X1 [KO:K04354 ]
121497471 PPP2R2B; serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B beta isoform isoform X1 [KO:K04354 ]
121482889 PPP2R3B; serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit beta isoform X1 [KO:K11583 ]
121478731 PPP2R3A; serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit alpha isoform X1 [KO:K11583 ]
121493493 PPP2R3C; serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit gamma isoform X1 [KO:K11583 ]
121471446 PPP2R5B; serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit beta isoform isoform X1 [KO:K11584 ]
121492115 PPP2R5A; serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform isoform X1 [KO:K11584 ]
121493034 PPP2R5E; serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit epsilon isoform isoform X1 [KO:K11584 ]
121493057 PPP2R5D; serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit delta isoform [KO:K11584 ]
121493453 PPP2R5C; serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform isoform X1 [KO:K11584 ]
121489233 EIF4EBP1; eukaryotic translation initiation factor 4E-binding protein 1 [KO:K07205 ]
121477352 PIK3CA; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [KO:K00922 ] [EC:2.7.1.153 ]
121478805 PIK3CB; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform [KO:K00922 ] [EC:2.7.1.153 ]
121499678 PIK3CD; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform isoform X1 [KO:K00922 ] [EC:2.7.1.153 ]
121481416 phosphatidylinositol 3-kinase regulatory subunit gamma isoform X1 [KO:K02649 ]
121496480 PIK3R1; phosphatidylinositol 3-kinase regulatory subunit alpha isoform X1 [KO:K02649 ]
121494738 PIK3R2; phosphatidylinositol 3-kinase regulatory subunit beta [KO:K02649 ]
121497986 LOW QUALITY PROTEIN: 26S proteasome regulatory subunit 4-like [KO:K03062 ]
121492781 NFKB1; nuclear factor NF-kappa-B p105 subunit isoform X1 [KO:K02580 ]
121479715 CHD4; chromodomain-helicase-DNA-binding protein 4 isoform X1 [KO:K11643 ] [EC:5.6.2.-]
121489374 DLA class I histocompatibility antigen, A9/A9 alpha chain-like isoform X1 [KO:K06751 ]
121489381 DLA class I histocompatibility antigen, A9/A9 alpha chain-like isoform X1 [KO:K06751 ]
121471640 class I histocompatibility antigen, Gogo-OKO alpha chain-like [KO:K06751 ]
121501728 LOW QUALITY PROTEIN: DLA class I histocompatibility antigen, A9/A9 alpha chain-like [KO:K06751 ]
121497830 ATP6V1B2; V-type proton ATPase subunit B, brain isoform [KO:K02147 ]
121491152 ATP6V1B1; V-type proton ATPase subunit B, kidney isoform [KO:K02147 ]
121490915 ATP6V1C2; V-type proton ATPase subunit C 2 isoform X1 [KO:K02148 ]
121480260 ATP6V1E1; V-type proton ATPase subunit E 1 isoform X1 [KO:K02150 ]
121471863 ATP6V1G2; V-type proton ATPase subunit G 2 isoform X1 [KO:K02152 ]
121500760 ATP6V1G3; V-type proton ATPase subunit G 3 isoform X1 [KO:K02152 ]
121472873 ATP6V0A1; V-type proton ATPase 116 kDa subunit a1 isoform X1 [KO:K02154 ]
121488304 ATP6V0C; V-type proton ATPase 16 kDa proteolipid subunit [KO:K02155 ]
121481676 ATP6V0B; V-type proton ATPase 21 kDa proteolipid subunit [KO:K03661 ]
121488003 PTGER4; LOW QUALITY PROTEIN: prostaglandin E2 receptor EP4 subtype [KO:K04261 ]
121477898 guanine nucleotide-binding protein G(s) subunit alpha isoform X1 [KO:K04632 ]
121480493 CREB1; cyclic AMP-responsive element-binding protein 1 isoform X1 [KO:K05870 ]
121489094 CREB3L2; cyclic AMP-responsive element-binding protein 3-like protein 2 [KO:K09048 ]
121484743 CREB3L4; cyclic AMP-responsive element-binding protein 3-like protein 4 isoform X1 [KO:K09048 ]
121501517 CREB3L1; cyclic AMP-responsive element-binding protein 3-like protein 1 [KO:K09048 ]
121494424 CREB3; cyclic AMP-responsive element-binding protein 3 isoform X1 [KO:K09048 ]
121494648 CREB3L3; cyclic AMP-responsive element-binding protein 3-like protein 3 [KO:K09048 ]
121474745 CREB5; cyclic AMP-responsive element-binding protein 5 isoform X1 [KO:K09047 ]
121480638 STAT1; signal transducer and activator of transcription 1-alpha/beta [KO:K11220 ]
121491356 STAT2; signal transducer and activator of transcription 2 isoform X1 [KO:K11221 ]
121493250 IRF9; LOW QUALITY PROTEIN: interferon regulatory factor 9 [KO:K04693 ]
121475835 2'-5'-oligoadenylate synthase-like protein 2 isoform X1 [KO:K14608 ]
121479319 MX2; interferon-induced GTP-binding protein Mx2 isoform X1 [KO:K14754 ]
121492778 NOTCH4; neurogenic locus notch homolog protein 4 isoform X1 [KO:K20996 ]
121489096 RBPJ; recombining binding protein suppressor of hairless isoform X1 [KO:K06053 ]
121477726 RBPJL; recombining binding protein suppressor of hairless-like protein [KO:K06053 ]
121481431 HEYL; hairy/enhancer-of-split related with YRPW motif-like protein isoform X1 [KO:K09091 ]
121484846 HEY2; hairy/enhancer-of-split related with YRPW motif protein 2 isoform X1 [KO:K09091 ]
121499136 HEY1; hairy/enhancer-of-split related with YRPW motif protein 1 [KO:K09091 ]
Compound
C05981 Phosphatidylinositol-3,4,5-trisphosphate
Reference
Authors
Moody CA, Laimins LA
Title
Human papillomavirus oncoproteins: pathways to transformation.
Journal
Reference
Authors
Chen J
Title
Signaling pathways in HPV-associated cancers and therapeutic implications.
Journal
Reference
Authors
Tummers B, Burg SH
Title
High-risk human papillomavirus targets crossroads in immune signaling.
Journal
Reference
Authors
Lehoux M, D'Abramo CM, Archambault J
Title
Molecular mechanisms of human papillomavirus-induced carcinogenesis.
Journal
Reference
Authors
Pang CL, Thierry F
Title
Human papillomavirus proteins as prospective therapeutic targets.
Journal
Reference
Authors
Yugawa T, Kiyono T
Title
Molecular mechanisms of cervical carcinogenesis by high-risk human papillomaviruses: novel functions of E6 and E7 oncoproteins.
Journal
Reference
Authors
Narisawa-Saito M, Kiyono T
Title
Basic mechanisms of high-risk human papillomavirus-induced carcinogenesis: roles of E6 and E7 proteins.
Journal
Reference
Authors
Wolf JK, Ramirez PT.
Title
The molecular biology of cervical cancer.
Journal
Reference
Authors
zur Hausen H
Title
Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis.
Journal
Reference
Authors
Kim YT, Zhao M
Title
Aberrant cell cycle regulation in cervical carcinoma.
Journal
Reference
Authors
McCance DJ
Title
Human papillomaviruses and cell signaling.
Journal
Reference
Authors
Motoyama S, Ladines-Llave CA, Luis Villanueva S, Maruo T
Title
The role of human papilloma virus in the molecular biology of cervical carcinogenesis.
Journal
Kobe J Med Sci 50:9-19 (2004)
Reference
Authors
Tommasino M
Title
The human papillomavirus family and its role in carcinogenesis.
Journal
Reference
Authors
Bello JO, Nieva LO, Paredes AC, Gonzalez AM, Zavaleta LR, Lizano M
Title
Regulation of the Wnt/beta-Catenin Signaling Pathway by Human Papillomavirus E6 and E7 Oncoproteins.
Journal
Reference
Authors
Shah M, Anwar MA, Park S, Jafri SS, Choi S
Title
In silico mechanistic analysis of IRF3 inactivation and high-risk HPV E6 species-dependent drug response.
Journal
Reference
Authors
James CD, Roberts S
Title
Viral Interactions with PDZ Domain-Containing Proteins-An Oncogenic Trait?
Journal
Reference
Authors
Ganti K, Broniarczyk J, Manoubi W, Massimi P, Mittal S, Pim D, Szalmas A, Thatte J, Thomas M, Tomaic V, Banks L
Title
The Human Papillomavirus E6 PDZ Binding Motif: From Life Cycle to Malignancy.
Journal
Reference
Authors
Subbaiah VK, Kranjec C, Thomas M, Banks L
Title
PDZ domains: the building blocks regulating tumorigenesis.
Journal
Reference
Authors
Banks L, Pim D, Thomas M
Title
Human tumour viruses and the deregulation of cell polarity in cancer.
Journal
Reference
Authors
Thomas M, Narayan N, Pim D, Tomaic V, Massimi P, Nagasaka K, Kranjec C, Gammoh N, Banks L
Title
Human papillomaviruses, cervical cancer and cell polarity.
Journal
Reference
Authors
Jayshree RS, Sreenivas A, Tessy M, Krishna S
Title
Cell intrinsic & extrinsic factors in cervical carcinogenesis.
Journal
Indian J Med Res 130:286-95 (2009)
Reference
Authors
Garnett TO, Duerksen-Hughes PJ
Title
Modulation of apoptosis by human papillomavirus (HPV) oncoproteins.
Journal
Reference
Authors
Zhang L, Wu J, Ling MT, Zhao L, Zhao KN
Title
The role of the PI3K/Akt/mTOR signalling pathway in human cancers induced by infection with human papillomaviruses.
Journal
Reference
Authors
Venuti A, Paolini F, Nasir L, Corteggio A, Roperto S, Campo MS, Borzacchiello G
Title
Papillomavirus E5: the smallest oncoprotein with many functions.
Journal
Reference
Authors
DiMaio D, Mattoon D
Title
Mechanisms of cell transformation by papillomavirus E5 proteins.
Journal
Reference
Authors
Ganguly N
Title
Human papillomavirus-16 E5 protein: oncogenic role and therapeutic value.
Journal
Reference
Authors
DiMaio D, Petti LM
Title
The E5 proteins.
Journal
Reference
Authors
De Marco F
Title
Oxidative stress and HPV carcinogenesis.
Journal
Reference
Authors
Wieringa HW, van der Zee AG, de Vries EG, van Vugt MA
Title
Breaking the DNA damage response to improve cervical cancer treatment.
Journal
Reference
Authors
Chung CH, Gillison ML
Title
Human papillomavirus in head and neck cancer: its role in pathogenesis and clinical implications.
Journal
Reference
Authors
Koromilas AE, Li S, Matlashewski G
Title
Control of interferon signaling in human papillomavirus infection.
Journal
Reference
Authors
Park JS, Kim EJ, Kwon HJ, Hwang ES, Namkoong SE, Um SJ
Title
Inactivation of interferon regulatory factor-1 tumor suppressor protein by HPV E7 oncoprotein. Implication for the E7-mediated immune evasion mechanism in cervical carcinogenesis.
Journal
Reference
Authors
Sandberg A, Lindell G, Kallstrom BN, Branca RM, Danielsson KG, Dahlberg M, Larson B, Forshed J, Lehtio J
Title
Tumor proteomics by multivariate analysis on individual pathway data for characterization of vulvar cancer phenotypes.
Journal
Reference
Authors
Zwerschke W, Mazurek S, Massimi P, Banks L, Eigenbrodt E, Jansen-Durr P
Title
Modulation of type M2 pyruvate kinase activity by the human papillomavirus type 16 E7 oncoprotein.
Journal
Reference
Authors
Lu Z, Hu X, Li Y, Zheng L, Zhou Y, Jiang H, Ning T, Basang Z, Zhang C, Ke Y
Title
Human papillomavirus 16 E6 oncoprotein interferences with insulin signaling pathway by binding to tuberin.
Journal
Reference
Authors
Xu M, Luo W, Elzi DJ, Grandori C, Galloway DA
Title
NFX1 interacts with mSin3A/histone deacetylase to repress hTERT transcription in keratinocytes.
Journal
Reference
Authors
Raff AB, Woodham AW, Raff LM, Skeate JG, Yan L, Da Silva DM, Schelhaas M, Kast WM
Title
The evolving field of human papillomavirus receptor research: a review of binding and entry.
Journal
Related pathway
vlg04612 Antigen processing and presentation
vlg04620 Toll-like receptor signaling pathway
KO pathway
LinkDB
All DBs